(0.51%) 5 154.05 points
(0.08%) 38 707 points
(0.58%) 16 250 points
(1.06%) $78.94
(4.81%) $2.25
(1.15%) $2 335.20
(3.60%) $27.65
(0.00%) $965.30
(-0.06%) $0.928
(-0.41%) $10.83
(-0.14%) $0.796
(-0.11%) $91.35
-0.91% $ 15.31
@ $15.42
Emitido: 13 feb 2024 @ 15:51
Retorno: -0.71%
Señal anterior: feb 13 - 13:32
Señal anterior:
Retorno: -0.39 %
Live Chart Being Loaded With Signals
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases...
Stats | |
---|---|
Volumen de hoy | 8.56M |
Volumen promedio | 1.05M |
Capitalización de mercado | 769.04M |
EPS | $0 ( 2024-04-04 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.96 |
ATR14 | $0.208 (1.36%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-19 | Ra Capital Management, L.p. | Sell | 638 668 | Common Stock |
2024-02-19 | Ra Capital Management, L.p. | Sell | 22 278 | Stock Option (Right to Buy) |
2024-02-19 | Ra Capital Management, L.p. | Sell | 17 000 | Stock Option (Right to Buy) |
2024-02-19 | Simpson Adam K. | Sell | 129 032 | Common Stock |
2024-02-19 | Simpson Adam K. | Sell | 191 449 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-94.10 |
Last 100 transactions |
Buy: 419 662 | Sell: 10 978 493 |
Volumen Correlación
Icosavax, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
KRTX | 0.968 |
FLXS | 0.96 |
ECHO | 0.953 |
YMAB | 0.952 |
IIN | 0.949 |
MRUS | 0.949 |
LIBY | 0.949 |
HQY | 0.948 |
LCUT | 0.948 |
META | 0.947 |
10 Correlaciones Más Negativas | |
---|---|
BIOL | -0.97 |
CYXT | -0.966 |
PRSO | -0.958 |
OSTK | -0.957 |
OMCL | -0.957 |
RVSB | -0.954 |
NSTG | -0.953 |
SOLO | -0.953 |
SGML | -0.95 |
ENNV | -0.946 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Icosavax, Inc. Correlación - Moneda/Commodity
Icosavax, Inc. Finanzas
Annual | 2022 |
Ingresos: | $582 000 |
Beneficio Bruto: | $-1.26M (-216.67 %) |
EPS: | $-2.23 |
FY | 2022 |
Ingresos: | $582 000 |
Beneficio Bruto: | $-1.26M (-216.67 %) |
EPS: | $-2.23 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
Ingresos: | $1.62M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.820 |
Financial Reports:
No articles found.
Icosavax, Inc.
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico